One of the most significant sources of conflicting interests in toxicology is financial relationships. Many toxicological studies are funded by industries whose products are being tested for safety. While industry funding is important for advancing research, it can potentially bias study outcomes. Researchers may consciously or unconsciously skew results in a way that favors the sponsor's interests. The challenge is to ensure that funding does not compromise scientific integrity, which can be addressed through transparency and disclosure of financial ties.
